GT-Repeat Polymorphism in the HO-1 Gene Promoter Is Associated with Risk of Liver Cancer: A Follow-Up Study from Arseniasis-Endemic Areas in Taiwan
The induction of heme oxygenase-1 (HO-1) has been shown to have therapeutic potential in experimental models of hepatitis and liver fibrosis, which are closely related to liver cancer. In humans, HO-1 induction is transcriptionally modulated by the length of a GT-repeat [(GT)n] in the promoter regio...
Main Authors: | Meei-Maan Wu, Fang-I Hsieh, Ling-I Hsu, Te-Chang Lee, Hung-Yi Chiou, Chien-Jen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/7/1489 |
Similar Items
-
Immune Modulation by Inhibitors of the HO System
by: Ayleen Fernández-Fierro, et al.
Published: (2021-12-01) -
Presence of an HO-1 expression threshold in renal glomeruli
by: Maria G Detsika, et al.
Published: (2015-12-01) -
Effect of heme oxygenase-1 polymorphisms on lung function and gene expression
by: Abboud Raja T, et al.
Published: (2011-09-01) -
Predictive role BLVRA mRNA expression in hepatocellular cancer
by: Kristýna Kubícková, et al.
Published: (2016-11-01) -
Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury
by: Maria G. Detsika, et al.
Published: (2021-01-01)